About: Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1986

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1986 (uk) article scientifique publié en 1986 (fr) im Dezember 1986 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1986 (ast) scientific article published on 01 December 1986 (en)
publication date	wds:Q69890524-92C7BA17-1DBA-4A18-A38D-DF40D95F68FD
publication date	1986-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69890524-38B6D2FD-270D-4CF9-854B-498CF960AA64
language of work or name	English
cites work	wds:Q69890524-1BA8E6BB-F6B6-419F-8D4A-DCF9F4CA5F6E wds:Q69890524-2B70CD38-AF22-4D3E-9E24-D8D1A9CA6767 wds:Q69890524-43D68CC8-1738-459D-B03B-F26346FE3415 wds:Q69890524-4CC67F07-ECA3-414F-B9FC-973D6E767302 wds:Q69890524-607BCCB1-DD97-43A1-97AB-C89ADF6B6746 wds:Q69890524-78A94226-613E-493B-A2E5-FDDF5EFF709D wds:Q69890524-82BCC6AB-4418-4D8C-BE13-F8A31E00E476 wds:Q69890524-A6740AE2-DBEA-4C6D-AD6F-FE0E688C5ADC wds:Q69890524-B1BB0D82-BD7D-4D21-A5E8-661EFCB88F44 wds:Q69890524-C28F2CC7-6CF6-43BB-977D-7D8BD27F935C wds:Q69890524-CCEEA5C9-1A05-43C5-8E21-69CAEEF69D38 wds:Q69890524-D17B6C5F-2E6F-4AB3-89E7-12C5ACBDEA74 wds:Q69890524-ED5A8E69-AC60-4A08-B5DE-AAFD8331DE3C wds:Q69890524-F380CCDC-F6D8-42E8-848C-1646537556D4
cites work	Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size Roentgen diagnosis of venous thrombosis in the leg Impedance plethysmography: the relationship between venous filling and sensitivity and specificity for proximal vein thrombosis The organisation of experimental venous thrombi Heparin and the in-hospital management of deep venous thrombosis: cost considerations Comparative effects of dicoumarol, tromexan, and heparin on thrombus propagation Studies in intravascular coagulation. IV. The effect of heparin and dicumarol on serum-induced venous thrombosis The Ultrasonic Velocity Detector in a Clinical Study of Venous Disease Thromboembolic complications during anticoagulant therapy Diagnosis and treatment of venous thromboembolism by consultants in Scotland. Thermography and phlebography in the detection of incompetent perforating veins
author name string	wds:Q69890524-2C2B8547-FD48-4C30-AE05-1D2A35AC07A4 wds:Q69890524-2EBCC925-42C0-4F1F-88B8-96530BFEF695 wds:Q69890524-AD882DB1-D611-4CC4-B300-5F5E546AA109 wds:Q69890524-BE78272B-AA8B-4891-BC2A-3A70B1216C76 wds:Q69890524-E16AD0CE-BB53-42D9-8843-AEFCF89BE9A8
author name string	A Gallus W Mills A Wycherley J Jackaman J Tillett
rdfs:label	Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism (en) Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism (nl)
skos:prefLabel	Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism (en) Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism (nl)
name	Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism (en) Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism (nl)
title	wds:Q69890524-880203B7-DE2E-4142-A56E-4E665DBC5FC3
title	Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism (en)
page(s)	wds:Q69890524-FB3AF166-F6B2-4511-B2DE-5020C665266D
page(s)	1293-1296
instance of	wds:Q69890524-382D2DE3-5AE4-4DE0-9CF4-FAC9DBFD5FDC
instance of	scholarly article
main subject	wds:Q69890524-03365B5B-4DCE-48B9-8AD0-AB1E5A29648F wds:Q69890524-EEAE6A36-9EB4-4644-BBD0-ED1B5389ED4C
main subject	(RS)-warfarin thrombosis
PubMed ID	wds:Q69890524-E233FEEA-EB77-4254-B660-F825A5AE3327
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2878173
PubMed ID	2878173
published in	wds:Q69890524-EAB50013-D9B2-4E76-8EA7-F9CEE1B30BF4
published in	The Lancet
issue	wds:Q69890524-08244B7E-4EB0-4DB8-82BB-61EB95DD8F2F
volume	wds:Q69890524-8F4F27BE-815D-497A-BCF5-31952E0F9EA2
issue	8519
volume	2
DOI	wds:Q69890524-FE5001C5-41E4-416D-8149-D7EFEFF900D3
DOI	http://dx.doi.org/10.1016/S0140-6736(86)91431-5
DOI	10.1016/S0140-6736(86)91431-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69890524
is cites work of	Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study Low molecular weight heparin treatment of venous thromboembolism Venous thromboembolic complications in children Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial Deep vein thrombosis Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism Uses of heparin Heparin-Induced Thrombocytopenia The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology Anticoagulants in venous thromboembolism Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement Free-floating deep venous thrombosis. A retrospective analysis Recurrent pulmonary embolism in patients treated because of acute venous thromboembolism: a prospective study Current data on the treatment of venous thromboembolic disease Management of oral anticoagulants in the treatment of venous thromboembolism Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial. Recent advances in the management of venous thromboembolism. Diagnosis and treatment of cancer-related thrombosis Prevention and treatment of venous thromboembolism

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software